Cannabinoids
![SAMHSA’s Fact Sheet Underscores the Potential Risks of CBD](https://aimedalliance.org/wp-content/uploads/2023/01/Iowa-MH--351x185.jpeg)
The rising popularity of cannabidiol (CBD) has ignited conversations about its potential benefits, but SAMHSA’s advisory fact sheet sheds light…
![Aimed Alliance’s New Resources on CBD Regulation and Labeling](https://aimedalliance.org/wp-content/uploads/2022/10/FDA-351x185.jpeg)
On Aug. 16, Aimed Alliance published two new resources addressing critical aspects of cannabidiol (CBD) regulation. The Food and Drug…
![Congress Requests Information on Regulation of CBD](https://aimedalliance.org/wp-content/uploads/2023/08/RFI-1-351x185.png)
On July 27, 2023, a bipartisan group of lawmakers issued a Request for Information (RFI) regarding the regulation of hemp-derived…
![Primary Care Providers Reluctant to Talk About CBD](https://aimedalliance.org/wp-content/uploads/2023/07/qtq80-pWFarw-351x185.jpeg)
Most primary care providers (PCPs) are hesitant to recommend cannabidiol (CBD) products to patients given doubts regarding the products’ safety…
![Connecticut Attorney General Shares Concerns on Unregulated Cannabis](https://aimedalliance.org/wp-content/uploads/2023/06/qtq80-iSMJkE-351x185.jpeg)
The office of the Attorney General recently announced a crackdown on unregulated THC products, like delta-8. Earlier this year, the…
![Pennsylvania Court Joins Several States in Requiring Employers to Reimburse Medical Cannabis](https://aimedalliance.org/wp-content/uploads/2023/04/qtq80-UpaNCU-351x185.jpeg)
On March 17, 2023, the Commonwealth Court of Pennsylvania held, in Fegley v. Firestone Tire & Rubber (Workers’ Comp. Appeal…
![DEA Concludes Delta-8 and Delta-9 THC-O are Controlled Substances](https://aimedalliance.org/wp-content/uploads/2020/12/AdobeStock_251993677EDIT-351x185.jpg)
On February 13, 2023, the Drug Enforcement Administration (DEA) responded to an inquiry by a North Carolina attorney regarding the…
![FDA Announces Need for New Regulatory Pathway for CBD](https://aimedalliance.org/wp-content/uploads/2022/10/FDA-351x185.jpeg)
On January 26, 2023, the Food and Drug Administration (Agency) announced that the existing regulatory frameworks are not appropriate for…
![FDA Publishes Final Guidance on Considerations for Clinical Research on Cannabis](https://aimedalliance.org/wp-content/uploads/2023/01/qtq80-IL7WnR-351x185.jpeg)
On January 23, 2023, the Food and Drug Administration (FDA) published a final guidance for industry, “Cannabis and Cannabis-Derived Compounds:…
![Aimed Alliance Publishes New Article in CONQUER Magazine on CBD and Consumer Safety](https://aimedalliance.org/wp-content/uploads/2020/11/AdobeStock_285593898EDIT-351x185.jpg)
On January 9, 2023, CONQUER Magazine published a piece written by Michael Barnes, Counsel to Aimed Alliance. CONQUER is a…